Risk of Heart Failure Hospitalization Associated With Cilostazol in Diabetes: A Nationwide Case–Crossover Study
Background and Objective: It has been suggested to avoid cilostazol, the first-line therapy for peripheral arterial disease, in patients with congestive heart failure (HF). The objective of this study was to evaluate the risk of hospitalization for heart failure (HHF) associated with cilostazol use...
Main Authors: | Cho-Kai Wu, Jou-Wei Lin, Li-Chiu Wu, Chia-Hsuin Chang |
---|---|
格式: | 文件 |
语言: | English |
出版: |
Frontiers Media S.A.
2019-01-01
|
丛编: | Frontiers in Pharmacology |
主题: | |
在线阅读: | https://www.frontiersin.org/article/10.3389/fphar.2018.01467/full |
相似书籍
-
Peripheral Nerve Denervation in Streptozotocin-Induced Diabetic Rats Is Reduced by Cilostazol
由: Kuang-Yi Tseng, et al.
出版: (2023-03-01) -
Risk of major adverse limb events in patients with type 2 diabetes mellitus receiving sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A population-based retrospective cohort study
由: Yen-Chieh Lee, et al.
出版: (2022-09-01) -
Effect of Baicalein on the Pharmacokinetics of Cilostazol and Its Two Metabolites in Rat Plasma Using UPLC-MS/MS Method
由: Qinghua Weng, et al.
出版: (2022-04-01) -
Cilostazol inhibits hyperglucose-induced vascular smooth muscle cell dysfunction by modulating the RAGE/ERK/NF-κB signaling pathways
由: Sheng-Chiang Su, et al.
出版: (2019-09-01) -
Antihypertensive agents and risk of Parkinson's disease: a nationwide cohort study.
由: Yen-Chieh Lee, et al.
出版: (2014-01-01)